Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats

Brain Research

Volumn 1453, Issue , 2012, Pages 64-76

  Vargas, Renata ^a   Rincón, Jaimar ^a   Pedreañez, Adriana ^a   Viera, Ninoska ^b   Hernández Fonseca, Juan P ^a   Peña, Caterina ^a   Mosquera, Jesús ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Angiotensin II; Brain; CD8; Diabetes; Enalapril; ICAM 1; Inflammation; Losartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CATALASE; CD8 ANTIGEN; ENALAPRIL; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN HOMOGENATE; CEREBELLUM; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; HISTOCHEMISTRY; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANGIOTENSIN II; ANIMALS; ANTIGENS, CD8; BLOOD GLUCOSE; BRAIN; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGES; MALE; MONOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SUPEROXIDES;

ANIMALIA; RATTUS;

EID: 84859802919     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.03.021     Document Type: Article

References (68)

1. Aebi, H.E., 1982. Catalase. In: Bergmeyer, H.U. (Ed.), Methods of Enzymatic Analysis. Verlg Chemie, Weinheim, Germany, pp. 271-282.
2. Allen, K.V., Frier, B.M., Strachan, M.W.J., 2004. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur. J. Pharmacol. 490, 169-175. (Pubitemid 38482170)
3. Alvarez, A., Cerda-Nicolas, M., Naim, A., Nabah, Y., Mata, M., Issekutz, A.C., Panés, J., Lobb, R.R., Sanz, M.J., 2004. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 104, 402-408. (Pubitemid 38900021)
4. Beckman, J.S., Koppenol, W.H., 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. Cell Physiol. 271, C1424-C1437.
5. Benigni, A., Cassis, P., Remuzzi1, G., 2010. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol. Med. 2, 247-257.
6. Biessels, G.J., Van Dam, P.S., 1997. Diabetic neuropathy: pathogenesis and current treatment perspectives. Neurosci. Res. Commun. 10, 1-10.
7. Brands, A.M., Biessels, G.J., Kappelle, L.J., de Haan, E.H., de Valk, H.W., Algra, A., Kessels, R.P., 2007. Utrecht Diabetic Encephalopathy Study Group. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement. Geriatr. Cogn. Disord. 23, 343-350. (Pubitemid 46631942)
8. Briceño, F.,Arcaya, J.L., Carrizo, E., Rincón, J., Mosquera, J., 2010. Forced swimming test decreases chemotactic responsiveness and expression of CD11a in ratmonocytes. Neuroimmunomodulation 17, 369-378.
9. Briggs, R.T., Robinson, J.M., Karnovsky, M.L., Karnovsky, M.J., 1986. Superoxide production by polymorphonuclear leukocytes. Histochemestry 84, 371-378.
10. Chai, W., Jan Danser, A.H., 2005. Is angiotensin II made inside or outside of the cell? Curr. Hyperten. Rep. 7, 124-127. (Pubitemid 40796732)
11. Chua, C.C., Hamdy, R.C., Chua, B.H., 1998. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta 1401, 187-194. (Pubitemid 28129101)
12. Crowley, S.D., Frey, C.W., Gould, S.K., Griffith, R., Ruiz, P., Burchette, J.L., Howell, D.N., Makhanova, N., Yan, M., Kim, H.S., Tharaux, P.L., Coffman, T.M., 2008. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am. J. Physiol. Renal Physiol. 295, F515-F524.
13. Dai, Q., Xu, M., Yao, M., Sun, B., 2007. Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats. Br. J. Pharmacol. 152, 1042-1048. (Pubitemid 350166045)
14. Deckert,M., Sanchez-Ruiz,M., Brunn, A., Schluter, D., 2010. Role of CD8 T-cell-mediated autoimmune diseases of the central nervous system. Crit. Rev. Immunol. 30, 311-326.
15. Dietrich, J.B., 2002. The adhesionmolecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 128, 58-68.
16. Doupis, J., Lyons, T.E., Wu, S., Gnardellis, C., Dinh, T., Veves, A., 2009. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J. Clin. Endocrinol. Metab. 94, 2157-2163.
17. Drake, C., Boutin, H., Jones, M.S., Denes, A., McColl, B.W., Selvarajah, J.R., Hulme, S., Georgiou, R.F., Hinz, R., Gerhard, A., Vail, A., Prenant, C., Julyan, P., Maroy, R., Brown, G., Smigova, A., Herholz, K., Kassiou, M., Crossman, D., Francis, S., Proctor, S.D., Russell, J.C., Hopkins, S.J., Tyrrell, P.J., Rothwell, N.J., Allan, S.M., 2011. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 25, 1113-1122.
18. Fleegal-DeMotta, M.A., Doghu, S., Banks, W.A., 2009. Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells. J. Cereb. Blood Flow Metab. 29, 640-647.
19. Folkersma, H., Foster-Dingley, J.C., van Berckel, B.N.M., Rozemuller, A., Boellaard, R., Huisman, M.C., Lammertsma, A.A., Vandertop, W.P., Molthoff, C.F., 2011. Increased cerebral (R)-[11C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study. J. Neuroinflammation 8, 67-73.
20. Friese, M.A., Fugger, L., 2009. Pathogenic CD8(+) T cells in multiple sclerosis. Ann. Neurol. 66, 132-141.
21. Greenwood, J., Etienne-Manneville, S., Adamson, P., Couraud, P.O., 2002. Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol. 38, 315-322. (Pubitemid 36398253)
22. Hartlage-Rübsamen, M., Schliebs, R., 2001. Sequential upregulation of cell adhesion molecules in degenerating rat basal forebrain cholinergic neurons and in phagocytotic microglial cells. Brain Res. 897, 20-26. (Pubitemid 32244348)
23. Hernández-Fonseca, J.P., Rincón, J., Pedreañez, A., Viera, N., Arcaya, J.L., Carrizo, E., Mosquera, J., 2009. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp. Diabetes Res. doi:10.1155/2009/329632.
24. Hoch, N.E., Guzik, T.J., Chen, W., Deans, T., Maalouf, S.A., Gratze, P., Weyand, C., Harrison, D.G., 2009. Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R208-R216.
25. Hölscher, C., 2011. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Biochem. Soc. Trans. 39, 891-897.
26. Jurewicz, M., McDermott, D.H., Sechler, J.M., Tinckam, K., Takakura, A., Carpenter, C.B., Milford, E., Abdi, R., 2007. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II induced inflammation. J. Am. Soc. Nephrol. 18, 1093-1102. (Pubitemid 46536895)
27. Kannel, W.B., McGee, D.L., 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA 241, 2035-2038.
28. Kaya, M., Kalayci, R., Küçük, M., Arican, N., Elmas, I., Kudat, H., Korkut, F., 2003. Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats. Life Sci. 73, 3235-3244. (Pubitemid 37237576)
29. Kierdorf, K., Wang, Y., Neumann, H., 2010. Immune-mediated CNS damage. Results Probl. Cell Differ. 51, 173-196.
30. Kitayama, H., Maeshima, Y., Takazawa, Y., Yamamoto, Y., Wu, Y., Ichinose, K., Hirokoshi, K., Sugiyama, H., Yamasaki, Y., Makino, H., 2006. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. Am. J. Hypertens. 19, 718-727. (Pubitemid 43928512)
31. Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.K., Fischer, R., Schwarz, I., Rahn, H.P., Plehm, R., Wellner, M., Elitok, S., Gratze, P., Dechend, R., Luft, F.C., Muller, D.N., 2009. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119, 2904-2912.
32. Last, D., Alsop, D.C., Abduljalil, A.M., Marquis, R.P., de Bazelaire, C., Hu, K., Cavallerano, J., Novak, V., 2007. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30, 1193-1199. (Pubitemid 46684647)
33. Leonard, B.E., 2007. Inflammation, depression and dementia: are they connected? Neurochem. Res. 32, 1749-1756. (Pubitemid 47428863)
34. Mastrocola, R., Restivo, F., Vercellinatto, I., Danni, O., Brignardello, E., Aragno, M., Boccuzzi, G., 2005. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J. Endocrinol. 187, 37-44. (Pubitemid 41556399)
35. McClain, J.A., Morris, S.A., Deeny, M.A., Marshall, S.A., Hayes, D.M., Kiser, Z.M., Nixon, K., 2011. Adolescent binge alcohol exposure induces long-lasting partial activation of microglia. Brain Behav. Immun. 25, S120-S128.
36. McCall, A.L., 2004. Cerebral glucose metabolism in diabetes mellitus. Eur. J. Pharmacol. 490, 147-158. (Pubitemid 38482168)
37. Mertens, B., Vanderheyden, P., Michotte, Y., Sarre, S., 2010. The role of central renin-angiotensin system in Parkinson's disease. J. Renin Angio. Aldo. Syst. 11, 49-56.
38. Medzhitov, R., Horng, T., 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9, 692-703.
39. Miklossy, J., Doudet, D.D., Schwab, C., Yu, S., McGeer, E.G., McGeer, P.L., 2006. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 197, 275-283. (Pubitemid 43077135)
40. Muñoz, M., Rincón, J., Pedreañez, A., Viera, N., Hernández-Fonseca, J.P., Mosquera, J., 2011. Proinflammatory role of angiotensin II in a rat nephrosismodel induced by adriamycin. J. Renin Angioten. Aldo. Syst. doi:10.1177/1470320311410092.
41. Nag, S., Kilty, D.W., 1997. Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke 28, 1028-1034.
42. Novak, V., Zhao, P., Manor, B., Sejdic, E., Alsop, D., Abduljalil, A., Roberson, P.K., Munshi, M., Novak, P., 2011. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care 34, 2438-2441.
43. O'Connor, J.C., Johnson, D.R., Freund, G.G., 2006. Psychoneuroimmune implications of type 2 diabetes. Neurol. Clin. 24, 539-559. (Pubitemid 44108537)
44. Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358. (Pubitemid 9194347)
45. Ohrui, T., Tomita, N., Sato-Nakagawa, T., Matsui, T., Maruyama, M., Niwa, K., Arai, H., Sasaki, H., 2004. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63, 1324-1325. (Pubitemid 39350046)
46. Pedreanez, A., Arcaya, J.L., Carrizo, E., Mosquera, J., 2006. Forced swimming test increases superoxide anion positive cells and angiotensin II positive cells in the cerebrum and cerebellum of the rat. Brain Res. Bull. 71, 18-22. (Pubitemid 44750416)
47. Pedreañez, A., Arcaya, J.L., Carrizo, E., Rincón, J., Viera, N., Peña, C., Vargas, R., Mosquera, J., 2011. Experimental depression induces renal oxidative stress in rats. Physiol. Behav. 104, 1002-1009.
48. Pelisch, N., Hosomi, N., Ueno, M., Nakano, D., Hitomi, H., Mogi, M., Shimada, K., Kobori, H., Horiuchi, M., Sakamoto, H., Matsumoto, M., Kohno, M., Nishiyama, A., 2011. Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in dahl salt-sensitive hypertensive rats. Am. J. Hypertens. 24, 362-368.
49. Perantie, D.C., Wu, J., Koller, J.M., Lim, A., Warren, S.L., Blackm, K.J., Sadler, M., White, N.H., Hershey, T., 2007. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30, 2331-2337. (Pubitemid 47359042)
50. Piotrowski, P., 2003. Are experimental models useful for analysis of pathogenesis of changes in central nervous system in human diabetes? Folia Neuropathol. 41, 167-174. (Pubitemid 37265156)
51. Pober, J.S., Sessa, W.C., 2007. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803-815. (Pubitemid 47480307)
52. Polidori, C., Ciccocioppo, R., Nisato, D., Cazaubon, C.,Massi,M., 1998. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment. Eur. J. Pharmacol. 352, 15-21. (Pubitemid 28359402)
53. Rees, D.A., Alcolado, J.C., 2005. Animal models of diabetes mellitus Diabetes UK. Diabetic Med. 22, 359-370.
54. Rincon, J., Pedreañez, A., Viera,N., Arcaya, J.L., Carrizo, E.,Mosquera, J., 2009. Depressive status does not alter renal oxidative and immunological parameters during early diabetic nephropathy in rats.World J. Biol. Psychiatry 10, 560-566.
55. Saavedra, J.M., 2011. Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell. Mol. Neurobiol. doi:10.1007/s10571-011-9754-6.
56. Sahmoun, A.E., Markland, M.J., Helgerson, S.D., 2007. Mental health status and diabetes among Whites and Native Americans: is race an effect modifier? J. Health Care Poor Underserved 18, 599-608.
57. Shelton, R.C., Miller, A.H., 2011. Inflammation in depression: is adiposity a cause? Dialogues Clin. Neurosci. 13, 41-53.
58. Smeda, J.S., Daneshtalab, N., 2011. The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke. J. Cereb. Blood Flow Metab. 31, 476-485.
59. Sundquist, K., Li, X., 2006. Type 1 diabetes as a risk factor for stroke in men and women aged 15-49: a nationwide study from Sweden. Diabet. Med. 23, 1261-1267. (Pubitemid 44600592)
60. Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., Egido, J., 2003. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881-900. (Pubitemid 36379329)
61. Turowski, P., Adamson, P., Greenwood, J., 2005. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell. Mol. Neurobiol. 25, 153-170. (Pubitemid 40558588)
62. Ullrich, O., Diestel, A., Eyüpoglu, I.Y., Nitsch, R., 2001. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell Biol. 3, 1035-1042. (Pubitemid 33130453)
63. van Kats, J.P., Schalekamp, M.A.D.H., Verdouw, P.D., Duncker, D.J., Danser, A.H., 2001. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int. 60, 2311-2317. (Pubitemid 33070473)
64. Wang, J.M., Tan, J., Leenen, F.H., 2003. Central nervous system blockade by peripheral administration of AT1 receptor blockers. J. Cardiovasc. Pharmacol. 41, 593-599. (Pubitemid 36373797)
65. Wiehelman, K., Braun, R., Fitzpatrick, J., 1988. Investigation of the bicin choninic acid protein assay. Identification of the groups responsible for color formation. Anal. Biochem. 175, 231-237.
66. Wright, J.W., Harding, J.W., 2011. Brain renin-angiotensin - a new look at an old system. Prog. Neurobiol. 95, 49-67.
67. Yan, J., Zhang, Z., Shi, H., 2011. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell. Mol. Life Sci. doi:10.1007/s00018-011-0731-5.
68. Zhang, M., Mao, Y., Ramirez, S.H., Tuma, R.F., Chabrashvili, T., 2010. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171, 852-858.